Poolbeg's Jeremy Skillington: "the results are as good as we hoped for"

Episode 1225,   Mar 02, 2023, 08:09 AM

Headliner
Share
Subscribe
Poolbeg #POLB CEO Jeremy Skillington talks to Vox Markets about the significance of the latest trial results for its flagship POLB 001 treatment for severe respiratory illness, and the drug's potentially significant role in delivering the new wave of cell-therapy cancer treatments.

To read the full RNS click here
Share
Subscribe
Next
Harald Braun of Guident: LOI with Auve Tech OÜ is “a step forward in creating safer, smart, and sustainable autonomous transportation”
Top episodes
Is a house price crash coming?
by The Vox Markets Podcast
Alastair Smith of Avacta: Successful Completion of Fourth Dose Escalation in AVA6000 Study
by The Vox Markets Podcast
Vox Markets Interview with Avacta CEO Alastair Smith
by The Vox Markets Podcast
Related episodes
Poolbeg Pharma PLC - Chief Executive Officer Jeremy Skillington PhD Talking To Zak Mir
by Share Talk LTD
Poolbeg Pharma FY Results:“ we’ve selected our development processes to be very cost efficient”
by The Vox Markets Podcast
The Exchange
by The Vox Markets Podcast